A Closer Look At Southeast Asia With Julien de Salaberry: An Interview With PharmAsia News (Part 1 of 2)
This article was originally published in PharmAsia News
The former Asian strategy exec with Merck sits down to talk about novel solutions for pharma companies in Southeast Asia, a fast-growing region with more than 600 million people.
You may also be interested in...
Merck Establishes JV With India's Sun Pharma To Develop Novel Combinations Of Branded Generics For Emerging Markets
MUMBAI - Merck & Co. is establishing a joint venture with India's Sun Pharmaceutical Industries Ltd. for a broad-based alliance to develop, manufacture and commercialize novel combinations and "incrementally innovative" branded generics in emerging markets, the two companies announced April 11
PharmAsia News looks ahead at 2015 to highlight expected trends and events shaping the biomedical community in Southeast Asia.
Southeast Asia in 2014 saw a continued push by several nations in the region to ink a Trans-Pacific Partnership pact that would potentially have a major impact on biological drugs. Also manufacturing and distribution saw a leap in the hub of Singapore as governments in the region ramped-up health spending.